BTSG · Earnings event · Q2 2026 · archived
BrightSpring Health Services, I (BTSG) Q2 2026 earnings — TrendMatrix coverage
Reported · EPS $0.45 vs estimate $0.40 (+13.0%) — classified BEAT.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Event detail · Q2 2026
EPS beat/miss and revenue
| Metric | Estimate | Actual | Surprise |
|---|---|---|---|
| EPS (diluted) | $0.40 | $0.45 | +13.0% |
| Revenue (2026-06-30) | — | $3.87B | — |
Revenue source: xbrl.
Verdict reaction
How the verdict moved around this report
Before this report, TrendMatrix rated BTSG Hold at 5.3/10. After the Q2 2026 report, the verdict moved to Buy (Wait) at 5.8/10.
Healthcare context
BTSG at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Health Information Services
- Market cap
- $12.21B
- P/E (fwd)
- 27.1
- P/E (ttm)
- 53.7
- 52-week range
- $22.46–$73.75
- Off 52-week high
- 16.0%
- RSI (14)
- 36
- Volume vs avg
- 0.51×
- Engine score
- 5.8/10
Live context at TrendMatrix’s latest engine read — updates after the report date; not frozen to it.